HØRSHOLM, Denmark--(BUSINESS WIRE)--In accordance with Section 29 of the Securities Trading Act LifeCycle Pharma A/S (OMX: LCP) today announced that LCP has received a notification from H. Lundbeck A/S that it has decreased its shareholdings in LCP from 15,313,816 shares, corresponding to 27.21%, to 0 shares.
